REGENXBIO to Host RGX-314 Program Analyst and Investor Event with Leading Retina Specialists
The agenda will include discussion on
The program will feature key opinion leaders and retina specialists, including:
John Pollack, M.D.
Illinois Retina Associates, Assistant Professor of Ophthalmology at Rush University Medical Center, and President of the American Society of Retina Specialists(ASRS) Pravin U. Dugel, M.D.
Subspecialty Day Board Chairman Emeritus for the
American Academy of Ophthalmology(AAO), Board of Directors and Executive Committee of ASRS and Board of Trustees of EURETINA, Clinical Professor at Roski Eye Instituteand University of Southern California Keck School of Medicine, and Managing Partner at Retinal Consultants of Arizona, Phoenix Jeffrey Heier, M.D.
Co-President, Medical Director and Retina Service Director of
Retina Research Ophthalmic Consultantsof Boston, and Principal Investigator of the RGX-314 Phase I/IIa clinical trial Allen C. Ho, M.D. Executive Committeeof the Retina Society, Professor of Ophthalmology at Sidney Kimmel Medical Collegeat Thomas Jefferson University, Director of Retina Researchat Wills Eye Hospital, and Investigator in the RGX-314 Phase I/IIa clinical trial
For any inquiries, kindly reach out to
To access the live webcast, visit the Investors section of
View original content to download multimedia:http://www.prnewswire.com/news-releases/regenxbio-to-host-rgx-314-program-analyst-and-investor-event-with-leading-retina-specialists-300795415.html